Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.

Jevremovic D, Gulati R, Hennig I, Diaz RM, Cole C, Kleppe L, Cosset FL, Simari RD, Vile RG.

Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H494-500.

PMID:
15277193
2.

Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.

Lee YK, So IS, Lee SC, Lee JH, Lee CW, Kim WM, Park MK, Lee ST, Park DY, Shin DY, Park CU, Kim YS.

J Gene Med. 2005 Feb;7(2):145-57.

PMID:
15546163
3.

[Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].

Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.

Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):943-8. Chinese.

PMID:
15329284
4.

Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

Bouquet C, Lamandé N, Brand M, Gasc JM, Jullienne B, Faure G, Griscelli F, Opolon P, Connault E, Perricaudet M, Corvol P.

Mol Ther. 2006 Aug;14(2):175-82.

PMID:
16600689
5.

Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.

Chester J, Ruchatz A, Gough M, Crittenden M, Chong H, Cosset FL, Diaz RM, Harrington K, Alvarez-Vallina L, Vile R.

Nat Biotechnol. 2002 Mar;20(3):256-63. Erratum in: Nat Biotechnol. 2006 Oct;24(10):1293. Loïc-Cosset, François [corrected to Cosset, François-Loïc].

PMID:
11875426
6.

Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display.

Nicklin SA, White SJ, Watkins SJ, Hawkins RE, Baker AH.

Circulation. 2000 Jul 11;102(2):231-7.

PMID:
10889136
7.

A mouse model for adenovirus gene delivery.

Tallone T, Malin S, Samuelsson A, Wilbertz J, Miyahara M, Okamoto K, Poellinger L, Philipson L, Pettersson S.

Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7910-5.

PMID:
11438737
8.

Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells.

Gulati R, Jevremovic D, Witt TA, Kleppe LS, Vile RG, Lerman A, Simari RD.

Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H512-7.

PMID:
15072951
9.

Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors.

Ferrari N, Glod J, Lee J, Kobiler D, Fine HA.

Gene Ther. 2003 Apr;10(8):647-56.

PMID:
12692593
10.

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.

Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4511-8.

PMID:
17671137
11.

Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.

Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C.

Gene Ther. 2006 Aug;13(16):1198-205.

PMID:
16617302
12.

Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.

Dalba C, Klatzmann D, Logg CR, Kasahara N.

Curr Gene Ther. 2005 Dec;5(6):655-67. Review.

PMID:
16457654
13.

Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.

Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K.

J Gene Med. 2009 May;11(5):373-81. doi: 10.1002/jgm.1313.

PMID:
19274675
14.

VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.

Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.

Gene Ther. 2006 Oct;13(20):1457-70.

PMID:
16724095
15.

Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.

Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS.

Circulation. 2005 Sep 13;112(11):1618-27.

PMID:
16145003
16.

Genetic manipulation of endothelial cells by viral vectors.

Lindemann D, Schnittler H.

Thromb Haemost. 2009 Dec;102(6):1135-43. doi: 10.1160/TH09-10-0724. Review.

PMID:
19967143
17.

Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cells.

Kealy B, Liew A, McMahon JM, Ritter T, O'Doherty A, Hoare M, Greiser U, Vaughan EE, Maenz M, O'Shea C, Barry F, O'Brien T.

Tissue Eng Part C Methods. 2009 Jun;15(2):223-31. doi: 10.1089/ten.tec.2008.0323.

PMID:
19196124
18.

Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.

Cashman SM, Bowman L, Christofferson J, Kumar-Singh R.

Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3496-504.

PMID:
16877421
19.

Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy.

Hamada K, Desaki J, Nakagawa K, Zhang T, Shirakawa T, Gotoh A, Tagawa M.

Mol Ther. 2007 Jun;15(6):1121-8.

PMID:
17387337
20.
Items per page

Supplemental Content

Support Center